Predicting peritoneal dissemination of gastric cancer in the era of precision medicine: molecular characterization and biomarkers
Y Chen, Q Zhou, H Wang, W Zhuo, Y Ding, J Lu, G Wu… - Cancers, 2020 - mdpi.com
Gastric cancer (GC) is a leading cause of worldwide cancer-related death. Being a highly
heterogeneous disease, the current treatment of GC has been suboptimal due to the lack of …
heterogeneous disease, the current treatment of GC has been suboptimal due to the lack of …
Molecular mediators of peritoneal metastasis in pancreatic cancer
LR Avula, B Hagerty, C Alewine - Cancer and Metastasis Reviews, 2020 - Springer
Pancreatic cancer is the third leading cause of cancer death in the USA, and pancreatic
ductal adenocarcinoma (PDA) constitutes 85% of pancreatic cancer diagnoses. PDA …
ductal adenocarcinoma (PDA) constitutes 85% of pancreatic cancer diagnoses. PDA …
[HTML][HTML] SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway
S Tian, P Peng, J Li, H Deng, N Zhan, Z Zeng… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
In this study, we investigated the role of SERPINH1 in gastric cancer (GC) progression. GC
patient tissues show significantly higher SERPINH1 mRNA and protein levels than normal …
patient tissues show significantly higher SERPINH1 mRNA and protein levels than normal …
A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics
H Wang, Y Ding, Y Chen, J Jiang, Y Chen, J Lu… - Gastric Cancer, 2021 - Springer
Background Gastric cancer (GC) is one of the leading causes of cancer deaths with high
heterogeneity. There is currently a paucity of clinically applicable molecular classification …
heterogeneity. There is currently a paucity of clinically applicable molecular classification …
Cell‑free DNA as a liquid biopsy for early detection of gastric cancer
ZB Huang, HT Zhang, B Yu, DH Yu - Oncology Letters, 2021 - spandidos-publications.com
Gastric cancer (GC) is one of the most common malignant tumors with poor prognosis
worldwide, mainly due to the lack of suitable modalities for population‑based screening and …
worldwide, mainly due to the lack of suitable modalities for population‑based screening and …
FNDC1 Promotes the Invasiveness of Gastric Cancer via Wnt/β-Catenin Signaling Pathway and Correlates With Peritoneal Metastasis and Prognosis
T Jiang, W Gao, S Lin, H Chen, B Du, Q Liu… - Frontiers in …, 2020 - frontiersin.org
Background Gastric cancer (GC) has a high morbidity and mortality rate, with peritoneal
metastasis (PM) identified as the main site of metastasis. Our previous study found that …
metastasis (PM) identified as the main site of metastasis. Our previous study found that …
Leisure activities, genetic risk, and Frailty: evidence from the Chinese adults aged 80 years or older
J Zhou, X Li, X Gao, Y Wei, L Ye, S Liu, J Ye, Y Qiu… - Gerontology, 2023 - karger.com
Introduction: About half of adults aged≥ 80 years suffer from frailty. Exercise is considered
effective in preventing frailty but may be inapplicable to adults aged≥ 80 years due to …
effective in preventing frailty but may be inapplicable to adults aged≥ 80 years due to …
[HTML][HTML] Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer
X He, Y Gu, Y Cao, B Hu, H Fang, Y Fei, K Lv… - European Journal of …, 2021 - Elsevier
Aim CD73 overexpression has been reported in several malignancies and is considered to
be a novel immune checkpoint. However, the role and significance of CD73 in gastric cancer …
be a novel immune checkpoint. However, the role and significance of CD73 in gastric cancer …
CST1 promoted gastric cancer migration and invasion through activating Wnt pathway
S Chen, Y Liu, K Zhang, L Chen - Cancer Management and …, 2021 - Taylor & Francis
Introduction Gastric cancer is one of the main reasons of cancer-induced death, exploring
the molecular mechanisms of gastric cancer progression is critical for gastric cancer therapy …
the molecular mechanisms of gastric cancer progression is critical for gastric cancer therapy …
Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer
W Zhang, F Shi, Y Kong, Y Li, C Sheng… - Cancer …, 2022 - Wiley Online Library
Purpose Protein tyrosine phosphatase receptor type T (PTPRT), which is a well‐known
phosphatase and mutates frequently in melanoma and non‐small cell lung cancer (NSCLC) …
phosphatase and mutates frequently in melanoma and non‐small cell lung cancer (NSCLC) …